Author: Customer Service
TORONTO, March 24, 2026 (GLOBE NEWSWIRE) —
AGF Investments Inc. (AGF Investments) today announced the March 2026 cash distributions for AGF Enhanced U.S. Equity Income Fund*, AGF Total Return Bond Fund* and AGF Systematic Global Infrastructure ETF, which pay monthly distributions, as well as AGF Global Sustainable Growth Equity ETF, which pays quarterly distributions. Unitholders of record on March 31, 2026 will receive cash distributions payable on April 7, 2026.
Details regarding the final “per unit” distribution amounts are as follows:ETF
Ticker
Exchange
Cash Distribution Per Unit ($)AGF Enhanced U.S. Equity Income Fund*
AENU
Cboe Canada Inc.
$0.181280AGF Total Return Bond Fund*
ATRB
Cboe Canada Inc.
$0.140000AGF Systematic Global Infrastructure ETF
QIF
Cboe Canada Inc.
$0.169008AGF Global Sustainable...
Dynacor Group Announces April 2026 Dividend
Written by Customer Service on . Posted in Public Companies.
MONTREAL, March 24, 2026 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor“ or the “Corporation“) announced today that its Board of Directors has approved a monthly dividend of C$0.01333 per common share (C$0.16 annually) for April 2026. This will be payable on April 17, 2026, to shareholders of record as of the close of business on April 9, 2026.
The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board.
About Dynacor
Dynacor Group is an ore processing company dedicated to producing gold sourced from artisanal miners. Since its establishment in 1996,...
Palvella Therapeutics to Host Full Year 2025 Financial Results Conference Call and Provide a Corporate Update on March 31, 2026
Written by Customer Service on . Posted in Public Companies.
WAYNE, Pa., March 24, 2026 (GLOBE NEWSWIRE) — Palvella Therapeutics, Inc. (“Palvella” or “the Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that the Company will report its full year 2025 financial results before market open on Tuesday, March 31, 2026. Palvella management will host a conference call for investors at 8:30 a.m. ET on that same day to discuss the results and provide a corporate update.
To access the live webcast of the call with slides, please click here or visit the “Events & Presentations” section of Palvella’s website. To access the...
HydroGraph and Sparc Technologies Team Up to Commercialize Graphene-Enhanced Coatings for Global Infrastructure Protection
Written by Customer Service on . Posted in Public Companies.
HydroGraph’s fractal graphene undergoing testing within ecosparc® additives designed to extend the life of steel assets in harsh environments
Partnership Targets US$33 Billion Protective Coatings Market
VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that it has entered into a Letter of Intent (“LOI”) dated March 23, 2026 with Sparc Technologies Limited (ASX: SPN) (FRA: NLR) (“Sparc”) to collaborate on the incorporation of HydroGraph’s Fractal Graphene™ into Sparc’s ecosparc® additives for protective coatings.
The LOI establishes a framework for joint testing, product development, and the potential commercial supply of graphene for ecosparc® additives. Subject to successful performance outcomes, the parties...
Athene Tops Annual Annuity Sales for Third Consecutive Year
Written by Customer Service on . Posted in Public Companies.
WEST DES MOINES, Iowa, March 24, 2026 (GLOBE NEWSWIRE) — Athene, the leading retirement solutions company and subsidiary of Apollo Global Management, Inc. (NYSE:APO), ranked number one in LIMRA’s 2025 U.S. Retail Annuity Survey for the third consecutive year, reinforcing the company’s leadership position as the top provider of guaranteed income solutions.
“Athene’s market leadership reflects the strength of the model we’ve built to serve our distribution partners and their clients,” said Sean Brennan, Co-President and Chief Commercial Officer, Athene USA. “The need for solutions that provide reliable retirement income remains clear, and Athene’s retail annuities continue to play an important role in helping individuals achieve greater financial security in retirement.”
Athene also ranked number one in several categories, including:Total...
Intermap Announces Date for Fourth Quarter and Full Year 2025 Financial Results
Written by Customer Service on . Posted in Public Companies.
DENVER, March 24, 2026 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced that it will release its fourth quarter and full year 2025 financial results after market close on March 31, 2026.
Intermap’s CEO Patrick A. Blott and CFO Jennifer Bakken will host a live webinar that same day at 5:00 pm ET to review the Company’s financial results and answer investor questions following the presentation.
Intermap welcomes shareholders, analysts, investors, media representatives, and other stakeholders to attend the webinar to discuss fourth quarter and full year 2025 results.
Conference Call DetailsDATE
March 31, 2026TIME
5:00 pm ETWEBCAST
Register
A replay of the webinar and supporting...
Rubicon Organics Reports 2025 Financial Results
Written by Customer Service on . Posted in Public Companies.
Delivered record net revenue of $59.5 million for 2025 (22% increase from 2024) and record quarterly net revenue of $16.5 million in Q4 2025 (up 16% from Q4 2024);Adjusted EBITDA1 of $5.0 million (25% increase from 2024) for the year ended December 31, 2025;Generated income from operations of $1.8 million, representing a turnaround from a loss of $1.2 million in 2024;Rapid scale-up of the Cascadia Facility with first harvests completed in February 2026.VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling premium and super-premium cannabis products, announces it has reported its financial results for the year ended December 31, 2025. All financial...
Concentrix Reports First Quarter 2026 Results
Written by Customer Service on . Posted in Public Companies.
Delivers revenue and profit within guidance
Maintains consistent full year outlook
Strong momentum in iX Suite enterprise winsNEWARK, Calif., March 24, 2026 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal first quarter ended February 28, 2026.
Three Months Ended
February 28, 2026
February 28, 2025
ChangeRevenue($M)
$
2,500.4
$
2,372.2
5.4
%Operating income($M)
$
118.6
$
168.9
(29.8)%Non-GAAP operating income($M)(1)
$
295.0
$
321.5
(8.2)%Operating margin
4.7
%
7.1
%
-240 bpsNon-GAAP operating margin(1)
11.8
%
13.6
%
-180 bpsNet income($M)
$
21.6
$
70.3
(69.3)%Non-GAAP net income($M)(1)
$
168.2
$
188.1
(10.6)%Adjusted EBITDA($M)(1)
$
348.2
$
374.2
(6.9)%Adjusted...
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
~ Delivered Record Annual Revenue with Full-Year Net PEDMARK® Product Sales of $44.6 Million, Representing 50% Year-Over-Year Growth, and Q4 2025 Net Product Sales of $13.8 Million, Representing 75% Growth Over Q4 2024 Net Product Sales ~
~ Executed on 2025 Clinical Data Strategy to Expand Real-World Validation of PEDMARK® Across New Tumor Types and Patient Populations Through Independent, Institution-Led Research ~
~ Achieved Record Performance with All-Time High Patient Enrollments and Conversion Rates in Q4 2025, Reflecting Strong Field Execution ~
~ Completed Oversubscribed $42 Million Equity Offerings with Participation from New and Existing Investors ~
~ Announced Positive Topline Results from Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss ~
~ Management to Host Conference Call...
Perma-Fix Reports 2025 Results as Expanded Capacity and Growing Backlog Support Hanford Cleanup Mission
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
PFNW permit renewal triples liquid processing capacity to 1.2 million gallons annually while backlog growth and international activity strengthen the Company’s growth platform
ATLANTA, March 24, 2026 (GLOBE NEWSWIRE) — Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) (the “Company”) today announced financial results and provided a business update for the fourth quarter and full year ended December 31, 2025.
Mark Duff, President and Chief Executive Officer of the Company, commented, “During 2025, we focused on strengthening Perma-Fix’s operational foundation and positioning the Company for the next phase of growth tied to the U.S. Department of Energy’s (“DOE”) Hanford cleanup mission. While the timing of certain government programs affected activity levels during the year, we continued to progress in preparing our facilities,...
